Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001367644-20-000033

EVP, Manufacturing & Tech Ops sold 16,094 shares at $60.00 ($965,640)

  • EVP, Manufacturing & Tech Ops acquired 10,428 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kirk Sean EVP, Manufacturing & Tech Ops 2020-04-06 Sale −5,666 $60.00 $339,960 12,571 D: show line 1 in the form
Kirk Sean EVP, Manufacturing & Tech Ops 2020-04-06 Option exercise +3,135 $30.86 $96,746 15,706 D: show line 2 in the form
Kirk Sean EVP, Manufacturing & Tech Ops 2020-04-06 Sale −3,135 $60.00 $188,100 12,571 D: show line 3 in the form
Kirk Sean EVP, Manufacturing & Tech Ops 2020-04-06 Option exercise +7,293 $30.63 $223,385 19,864 D: show line 4 in the form
Kirk Sean EVP, Manufacturing & Tech Ops 2020-04-06 Sale −7,293 $60.00 $437,580 12,571 D: show line 5 in the form
Open-market sales · 16,094 sh · avg $60.00 · $965,640

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kirk Sean EVP, Manufacturing & Tech Ops 2020-04-06 Sale · Employee Stock Options (Right to Buy) −3,135 $60.00 $188,100 38,805 D: show line 6 in the form
Kirk Sean EVP, Manufacturing & Tech Ops 2020-04-06 Sale · Employee Stock Options (Right to Buy) −7,293 $60.00 $437,580 31,512 D: show line 7 in the form
Loading xslF345X03/wf-form4_158639155760496.xml…